VICC toll-free number
1-877-936-8422

The VICC.ORG Directory of Doctors, Healthcare Providers & Researchers

R. Daniel Beauchamp, M.D.

John Clinton Foshee Distinguished Chair in Surgery
Professor of Surgery
Professor of Cancer Biology
Chair of the Section of Surgical Sciences
VICC Member
Surgical Oncologist

  • Appointments
    615-322-2064
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Vanderbilt Breast Center One Hundred Oaks
    615-322-2064; Referring Physicians: 615-343-9283

    Office
    615-322-2363
  • Faxes
    Vanderbilt Breast Center One Hundred Oaks Fax
    615-343-7622
  • Addresses
    Vanderbilt Breast Center One Hundred Oaks
    719 Thompson Lane, Suite 25000
    Nashville, TN 37204
    Website

    Office
    Vanderbilt University Medical Center
    D-4316 Medical Center North
    Nashville, TN 37232-2729

Profile

R. Daniel Beauchamp, M.D., F.A.C.S., has a clinical practice focused in Surgical Oncology. He cares for patients with a broad spectrum of malignancies, including gastrointestinal tract cancers including esophageal and colorectal cancers, breast cancer, melanoma and soft tissue sarcoma. Dr.
Read more ....

R. Daniel Beauchamp, M.D., F.A.C.S., has a clinical practice focused in Surgical Oncology. He cares for patients with a broad spectrum of malignancies, including gastrointestinal tract cancers including esophageal and colorectal cancers, breast cancer, melanoma and soft tissue sarcoma. Dr. Beauchamp participates in the multidisciplinary GI Oncology clinic every Wednesday and holds clinic in the Vanderbilt Breast Center on Thursday mornings.

Dr. Beauchamp is the John Clinton Foshee Distinguished Professor of Surgery, Chairman of the Section of Surgical Sciences, and Surgeon-in-Chief of Vanderbilt University Hospital and has held these positions since July 2001. He also has joint appointments as Professor in the departments of Cell and Developmental Biology and Cancer Biology. He also serves as Associate Director for Clinical/Translational Programs in the Vanderbilt-Ingram Cancer Center. Dr. Beauchamp joined the faculty of the Vanderbilt University Medical Center as Associate Professor in the Department of Surgery, Division of Surgical Oncology and Associate Professor of Cell Biology in December 1994. He served as the chief of the Division of Surgical Oncology from 1997 until 2001 when he assumed his current position as Chief of Surgery. His ongoing institutional administrative responsibilities also include the Chair of the Perioperative Enterprise Committee, and service on the Perioperative Executive Committee, the VMG Executive Committee, the Medical School Executive Committee, the Clinical Enterprise Group, the Quality Council, the ELEVATE Steering Committee, and the Surgical Critical Care Steering Committee.

In addition to clinical practice and administrative responsibilities, Dr. Beauchamp is an active investigator in the field of cancer biology and cancer clinical trials. He has published over 100 peer-reviewed articles in these fields and has had continuous funding from the National Institutes of Health for more than 18 years.

Education

  • B.S., Texas Tech University, Lubbock, Texas, 1978
  • M.D., The University of Texas Medical Branch, Galveston, Texas, 1982

Research Description

R. Daniel Beauchamp, MD, is the John Clinton Foshee Distinguished Professor of Surgery, Chairman of the Section of Surgical Sciences, and Surgeon-in-Chief of Vanderbilt University Hospital and has held these positions since July 2001 and on the faculty at Vanderbilt since December 1994. He holds joint appointments as professor in the departments of Cell and Developmental Biology and Cancer Biology. He also serves as Deputy Director of the Vanderbilt-Ingram Cancer Center. Dr. Beauchamp has two active R01 grants from NIH, and leads one of the main projects in the GI Cancer SPORE. Dr. Beauchamp's primary area of research interest has been in colorectal carcinogenesis, the biology of cancer cell invasion and metastasis, and in the identification of novel molecular biomarkers and therapeutic targets in colorectal and other alimentary tract malignancies. His work applies DNA microarray and proteomic technology to identify novel biomarkers and therapeutic targets in human colorectal cancer samples. He also uses molecular genetics, chemical biology and cell biological approaches to examine mechanistic questions in cancer biology in both cell culture and mouse models. In addition to the basic cancer research Dr. Beauchamp works in collaboration with his Medical Oncology and Radiation Oncology colleagues to accrue cancer patients to approved clinical trials. He has trained and mentored numerous junior faculty members, physician scientist fellows, medical students, graduate students and post-doctoral fellows in his laboratory. He is one of the few surgeon members of the ASCI.

Clinical Research Description

Dr. Beauchamp's clinical practice is primarily in General Surgical Oncology. He participates in the multidisciplinary gastrointestinal oncology clinic. Dr. Beauchamp's practice includes patients ith tumors of the esophagus, stomach, pancreas, colon and rectum. His group is actively pursuing improvement in outcomes for these tumors through application of multimodality therapy. In addition, Dr. Beauchamp has a large breast cancer and melanomapractice. He and his partners are skilled in the use of Sentinel lymph node mapping techniques and, stereotactic breast biopsy and participate in a multidisciplinary team along with Radiologists, Medical Oncologists, Pathologists, Radiation Oncologists and the Genetic counseling service to provide the most current and comprehensive diagnostic and therapeutic care available.

Publications


You do not have JavaScript enabled. This site works better with JavaScript turned on.